Introduction
Continuous positive airway pressure (CPAP) remains the gold standard treatment for obstructive sleep apnea (OSA). CPAP titration can be done using manual titration or using autotitrating continuous positive airway pressure (APAP) devices. Moreover, CPAP titration can be done using full-night or split-night protocol. The aim of the study was to compare between the use of APAP and manual titration to determine the needed CPAP pressure during split-night polysomnography for diagnosis and treatment of OSA. Patients and methods A total of 100 patients with severe OSA were enrolled after exclusion of patients with heart failure or respiratory failure. After diagnostic polysomnography, patients were divided into two groups: group 1 was offered manual CPAP titration and group 2 was offered APAP titration. The time for CPAP titration was at least 4 h in both groups.
Results
Both groups were matched regarding age, sex, BMI, sleep parameters, and apnea-hypopnea index (44.52±7.81/h in group 1 and 42.66±9.68/h in group 2 with no statistical significance). After CPAP titration, apnea-hypopnea index was significantly improved in both groups. The time needed to reach the therapeutic pressure was significantly lower in group 2 than in group 1. Moreover, attended technician was needed only in group 1.
Conclusion
The use of APAP was equal to manual titration in this group of patients with severe OSA, with decreased cost and lesser time to reach the therapeutic pressure. Large multicenter trials are needed to modify the guidelines in view of using APAP in splitnight protocol for diagnosis and treatment of OSA.
Introduction
Obstructive sleep apnea can be described as a disorder in which there is repetitive collapse of the upper airway during sleep leading to respiratory events (apnea and hypopnea). Excessive daytime sleepiness, impaired daytime function, exacerbation of metabolic comorbidities (e.g. impaired glucose tolerance, insulin resistance, type 2 diabetes mellitus, and dyslipidemia), increased risk of cardiovascular accidents, chronic kidney disease, and mortality are among the potential consequences of obstructive sleep apnea (OSA). Type 2 diabetes mellitus, chronic kidney disease, and left ventricular heart failure appear to have bidirectional risk association with OSA/hypopnea syndrome [1] . After diagnosis of OSA has been established, prompt decision whether treatment is indicated or not has to be made and, if so, which type of therapy is most suitable. Positive airway pressure (PAP) therapy is the first-line therapy [1] . Selection of a mode of PAP, device setting (s), and a patient-device interface are three cornerstones for initiation of PAP therapy. Titration is then required to reach the optimal amount of PAP needed. Therapeutic targets of titration include determination of a level of PAP that is acceptable to the patient, elimination of recurrent upper airway obstruction during sleep, and maintenance of both sleep continuity and an acceptable oxyhemoglobin saturation during sleep [2] . Titration strategy begins with a low pressure level (4 cm H 2 O is recommended). The pressure is serially increased (usually in increments of 1-2 cm H 2 O) until evidence of upper airway obstruction is eliminated, allowing at least 2 min at each pressure. The minimal amount of continuous positive airway pressure (CPAP) that consistently prevents upper airway obstruction becomes the therapeutic CPAP pressure. The target CPAP pressure should abolish snoring, apneas, hypopneas, respiratory effort-related arousals, and/or episodic oxyhemoglobin desaturation [2, 3] . Manual titration of fixed CPAP should be performed during laboratory polysomnography (PSG) including all physiologic monitoring devices necessary to identify apneas (including recognition of obstructive vs. central mechanisms), hypopneas, respiratory effort-related arousals, and snoring. Protocols for fixed CPAP titration include a full-night in-laboratory PSG, splitnight in-laboratory PSG, or in-home titration using an autotitrating continuous positive airway pressure (APAP) device [1] . Titration during a full-night, attended, in-laboratory PSG is the gold standard strategy to which other titration strategies are compared [1, 4] . The definition of split-night study is an attended, in-laboratory PSG during which a diagnostic portion is followed by a PAP titration. Titration is performed only if the diagnostic portion of the study identifies OSA. An APAP could be employed during the titration phase [1, 5] . The patient is offered APAP, which contains event detection software to estimate the apnea-hypopnea index (AHI), hours of use, and presence or absence of a mask leak. The prescriber must specify the minimal and maximal CPAP pressures; usually a minimum of 5 cm H 2 O and maximum of 20 cm H 2 O will be convenient for most patients. The level of pressure that eliminates all evidence of upper airway obstruction for more than 90 or 95% of the time (depending on the device model) becomes the therapeutic CPAP pressure. AHI measured by APAP devices is only an estimate of the AHI that might be measured in the sleep laboratory, although studies suggest good correlation if the AHI is either fairly high or less than 10 [6, 7] . It is to be noted that guidelines for scoring respiratory events include the presence of oxyhemoglobin desaturation and/or arousal from sleep, neither of which is measured by autotitrating devices. In addition, the degree of airflow reduction used to score a respiratory event may not adhere to published guidelines [8] .
Thus, the aim of the present study was to compare between the use of APAP and manual titration to determine the needed CPAP pressure during splitnight polysomnography for diagnosis and treatment of OSA.
Patients and methods
The study was done in the sleep laboratory of the Chest Disease Department, Faculty of Medicine. Alexandria University. The study included 100 patient with severe OSA (proved by polysomnography with AHI >30/h of sleep). Patients were randomly selected from those attending to the sleep clinic. The study was done in the period between 1 February 2017 to 30 September 2017. Written consent was taken from all patients before enrollment in the study, and the study was approved by the administrative council of chest disease department and by the ethical committee of the Faculty Of Medicine, Alexandria University.
Exclusion criteria
The exclusion criteria were as follows:
(1) Patients with mild to moderate OSA.
(2) Patients with acute heart failure. 
Diagnostic polysomnography
Polysomnography was done for all patients using SOMNOscreen (Somnomedics, Germany). The minimal time for diagnostic polysomnography was 4 h, and the following channels were included in the recording:
(1) Electroencephalogram (C3-A2, C4-A1).
(2) Electrooculogram.
(3) Electromyogram. (4) Airflow assessment using nasal thermistor and pressure sensor. Polysomnography scoring was done manually according to the guidelines of American Academy of Sleep Medicine (AASM) [9] .
Continuous positive airway pressure titration [2] After accomplishment of the diagnostic portion of the study, patients were randomized − during this split night − to determine the exact pressure needed to treat the condition into two groups:
(1) Group 1 was subjected to manual titration using fixed CPAP device. (2) Group 2 was subjected to automatic CPAP titration using auto CPAP device.
Group 1
It included 50 patients who underwent manual titration to define the therapeutic pressure most tolerated by the patient and at the same time that relieves the upper airway obstruction during sleep demonstrated by decrease in AHI, and disappearance of snoring.
CPAP machine was demonstrated to the patient and its mechanism of action was explained before use. CPAP titration was started at a low pressure as recommended (4 cm H 2 O) and increased by 1-2 cm H 2 O increments in periods not less than 10 min.
The patient was considered to have optimal titration if CPAP pressure reduces respiratory disturbance index (RDI) to less than 5/h of sleep for 15 min or more and with supine REM sleep at the selected pressure not interrupted by spontaneous arousals or awakenings.
The patient was considered to have good titration if CPAP pressure reduces RDI to 10 or less per hour of sleep and supine REM sleep achieved not continually interrupted by spontaneous arousals or awakenings at the selected pressure.
The patient was considered to have adequate titration if CPAP pressure does not reduce the RDI to 10 or less per hour of sleep but reduces the RDI by 75% from baseline (especially in severe OSA patients), or criteria for optimal or good titration are met with the exception that supine REM sleep did not occur at the identified pressure.
The patient is considered to have unacceptable titration (failure) if it does not meet any one of the aforementioned grades.
Group 2
It included 50 patients who underwent CPAP titration using Auto CPAP (ResMed, Australia). The patient was given APAP, which contains event detection software providing estimates of the AHI, hours of use, and presence or absence of a mask leak.
The minimum and maximum CPAP pressures were specified by the prescriber; usually a minimum of 5 cm H 2 O and maximum of 20 cm H 2 O. The level of pressure that eliminates all evidence of upper airway obstruction for more than 90 or 95% of the time becomes the fixed CPAP setting.
The duration of time allowed for CPAP titration in both groups was at least 4 h.
Statistical analysis
Statistical package for the social sciences (SPSS version 20; SPSS Inc., Chicago, Illinois, USA) software was used for analysis of the results. All data in this study were presented as mean±SD. Independent sample t-test was used to compare between the two groups. Statistical significance was considered if P value less than 0.05.
Results
The study included 100 patients with severe OSA who were divided into two groups. All epidemiologic and diagnostic polysomnographic data of both groups are represented in Table 1 . After accomplishment of the diagnostic portion of the night, all patients were offered CPAP titration either manually or using auto CPAP. Patients who did not tolerate the CPAP were excluded from the study. Data illustrating outcomes of CPAP titration and therapeutic pressure reached are demonstrated in Table 2 .
From Table 2 , it is evident that patients in both groups were markedly improved on CPAP as evidenced by marked decrease in AHI (Fig. 1) . In group 1, AHI before CPAP was 44.52±7.81, and after CPAP, it decreased to 6.1±2.3/h of sleep (P<0.05), and in group 2, AHI before CPAP was 42.66±9.68, and after CPAP, it decreased to 5.4±2.8/h of sleep (P<0.05).
Looking at other features of titration in both groups:
(1) Presence of specialized technician during titration portion of the study was mandatory in group 1 whereas it was not needed in group 2. (2) The time needed to reach the therapeutic pressure was significantly higher in group 1 (82.3±11.2 min) than in group 2 (34.22±5.6 min) (P<0.05; Fig. 2 ). (3) Optimal titration was achieved in higher percentage in group 2 (56%) than in group 1 (40%) (Fig. 3) . (4) The therapeutic CPAP pressure was lower in group 2 than in group 1, but the difference was statistically insignificant (Fig. 4) .
Discussion
Titration during a full-night, attended, in-laboratory PSG is the gold standard approach to which other titration strategies are compared. This approach is appropriate for the initiation of CPAP and BPAP [1, 4] . Kapur et al. [4] in 2017 suggested − as a weak recommendation − that, if clinically appropriate, a split-night diagnostic protocol can be used if there is no condition to interfere with successful diagnosis and treatment of OSA. This recommendation was based on initiating CPAP titration only when the following criteria are met: (a) presence of moderate to severe OSA in a minimum diagnostic period of 2 h, and (b) CPAP titration to take 3 h or more. A split-night study has acceptable accuracy to diagnose OSA in an uncomplicated adult patient and may improve efficiency of care when done in high-quality technical centers. The advantage of split-night protocol is that it can establish a diagnosis of OSA and define the therapeutic PAP pressure within one night. A split-night study may be preferred because of AHI, apnea-hypopnea index; CPAP, continuous positive airway pressure; ODI4%, oxygen desaturation index; T90, sleep time with oxygen saturation below 90% in relation to total sleep time; TST, total sleep time.
Figure 1
Apnea-hypopnea index before and after continuous positive airway pressure in both groups (events per hour of sleep).
cost savings using one instead of two study nights. Among nine studies [10] [11] [12] [13] [14] [15] [16] [17] [18] done in this field, three focused on diagnostic accuracy of the first part of the PSG [11, 12, 16] , and a fourth study compared the diagnostic portion of a split-night versus a separate full-night study [13] . Three studies compared success of CPAP titration in the two protocols [15] [16] [17] . One study compared CPAP compliance after titration using the two protocols [14] . Another study examined cost-effectiveness of the two protocols, and the results were considered in the evaluation of resources [10] . The four studies that focused on the diagnosis of OSA compared the first part of the split night with the whole-night protocol [11] [12] [13] 17] . One study found that the AHI reached within 2-3 h of recording was strongly correlated with the AHI reached by whole night even in those with mild degree of OSA [11] . The other two studies found the same results, especially when the recording time in the first part of split-night protocol was more than 90 min [12, 13] . Finally, a study that compared sleep and respiratory parameters of both protocols did not find a significant difference in AHI [17] . Regarding the three studies that discuss CPAP success in both protocols [14] [15] [16] , they did not find significant difference between both protocols regarding AHI, arousal index, or oxygen saturation during sleep while using the CPAP or even CPAP adherence after titration, but one study found that CPAP pressure was lower in the split-night protocol than in the wholenight protocol [16] . Most experts agree with an AASM clinical guidelines that specify at least a 2-h diagnostic phase and a minimum AHI indicative of quite severe OSA (AHI ≥40/h) before proceeding to a PAP titration [1] . However, the same AASM guideline also indicates that a split-night study may be performed based on 'clinical judgment' when AHIs are between 20 and 40/h. The factors that could contribute to this clinical judgment are not stated, although a previous AASM practice parameter mentions 'repetitive long obstructions and major desaturations' as examples [19] . As these are given only as examples, room is clearly left for arriving at a clinical judgment to split a study using other considerations, and qualifying AHIs as low as 20/h have been commonly adopted in clinical practice. Attention must also be paid to time constraints, in that at least 3 h of PSG time should be available for adequate titration [4] . To determine a fixed level of CPAP in uncomplicated patients, it is suggested that an attended in-laboratory CPAP titration with a fixed level device or an unattended in-home titration using an APAP device be used. Other approaches using prediction formulas or empiric titration strategies are not as well validated and are not typically used by clinicians in practice. These approaches, if utilized, are typically reserved for experts who manage patients with uncomplicated OSA. Fixed level CPAP delivers PAP at a level that remains relatively constant throughout the respiratory cycle. An attended in-laboratory CPAP titration involves a graduated increase in CPAP in a PSG-monitored setting. Titration by an attending sleep technologist occurs in the sleep laboratory, thereby requiring an Time to reach the therapeutic pressure in both groups (min).
Figure 3
Percentage of (optimal) titration in both groups.
Figure 4
Value of therapeutic continuous positive airway pressure reached in both groups (cmH 2 O).
overnight stay. APAP delivers an amount of PAP that varies during sleep. Autotitrating PAP devices utilize proprietary algorithms to resolve obstructive sleepdisordered breathing as detected by the device. They can be used to determine a fixed CPAP setting for patients with uncomplicated OSA [5, [20] [21] [22] . Variations in APAP titration protocols include different durations of time (e.g. 3-14 days) using the APAP to determine an optimal pressure, different APAP ranges, and different definitions of trial success. However, in the absence of consensus, shorter or longer periods can also be tried. There is also no consensus on the appropriate initial APAP range, which typically varies from 5 to 20 cm H 2 O; the range can be further adjusted based on the presence or absence of symptoms and on data calculated from the device. The optimal fixed CPAP setting is typically the level of pressure at or below which obstructive events measured by the APAP device are eliminated for more than 90 or 95% of the time ('P90 and P95 pressure') [23] . APAP devices are more commonly used in an in-home unattended setting (i.e. without polysomnographic monitoring), as their main advantage is that they eliminate the need for an overnight stay in a sleep laboratory. Although an attended in-laboratory autotitration of CPAP is technically feasible, it is only occasionally performed to determine initial settings, or to assess efficacy of APAP for a given patient. Split-night studies are not practical for unattended in-home settings with autotitrating devices, as these devices have not been validated for the diagnosis and management of OSA in most patients [24] [25] [26] [27] [28] . Therefore, we tried in this study to modify and change the guidelines in view of using APAP in split-night protocol for diagnosis and treatment of severe uncomplicated cases of OSA in view of promising results: presence of specialized technician during titration portion of the study was mandatory in group 1, whereas it was not needed in group 2; the time needed to reach the therapeutic pressure was significantly higher in group 1 (82.3±11.2 min) than in group 2 (34.22±5.6 min) (P<0.05); and the optimal level of titration was achieved in higher percentage in group 2 (56%) compared with group 1 (40%), as well as a lower therapeutic CPAP pressure was seen in group 2 than in group 1, without statistical significance.
Conclusion
Use of APAP was equal to manual titration in this group of patients with severe OSA, with decreased cost and lesser time to reach the therapeutic pressure. Large multicenter trials are needed to modify the guidelines in view of using APAP in split-night protocol for diagnosis and treatment of OSA.
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